Novartis Institutes for Biomedical Research Business Analyst Salary
The average Novartis Institutes for Biomedical Research Business Analyst earns an estimated $87,789 annually, which includes an estimated base salary of $78,251 with a $9,537 bonus. Novartis Institutes for Biomedical Research's Business Analyst compensation is $4,318 more than the US average for a Business Analyst. Business Analyst salaries at Novartis Institutes for Biomedical Research can range from $40,000 - $200,000.
The Marketing Department at Novartis Institutes for Biomedical Research earns $1,268 more on average than the Finance Department.
Last updated 3 years ago.
- $78,251
- avg. base
- $9,537
- avg. bonus
Business Analyst Salaries at Novartis Institutes for Biomedical Research
Business Analysts earn $3,164 more than Business Analysts, and $15,424 less than Marketing Managers.
Compensation at Novartis Institutes for Biomedical Research by Department
The Marketing Department averages $1,268 more than the Finance Department, and $3,375 less than the Sales Department
Business Analyst Compensation by Gender (All Companies)
The average female Business Analyst at companies similar size to Novartis Institutes for Biomedical Research reported making $85,427, while the average male Business Analyst at similar sized companies reported making $93,384.
Business Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Analyst at companies similar size to Novartis Institutes for Biomedical Research reported making $97,000, while the average African American/Black Business Analyst at similar sized companies reported making $76,443.
How Business Analysts at Novartis Institutes for Biomedical Research Rate Their Compensation
The majority of Business Analysts at Novartis Institutes for Biomedical Research believe they're compensated fairly. 100% of Business Analysts at Novartis Institutes for Biomedical Research say they receive annual bonuses, and the majority (43%) are not satisfied with their benefits. See more compensation ratings at Novartis Institutes for Biomedical Research
